Researchers and end users jointly develop forward-looking health technologies with funding of €4 million

- Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock

- Series C round was supported by both existing and new investors

Although menopause – also known as perimenopause – can significantly impair women's well-being and performance, medical education and support have often been inadequate to date. As part of the joint project “PETRA: AI-supported, educational therapy…

Highly Cited Researchers 2025 list published

– Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing

– TK-6302 Clinical Trial Application planned in Q4 2025 for initiation of the Phase 1 ATLAS trial…

Researchers from the Institute of Neurophysiology at Charité – Universitätsmedizin Berlin have uncovered new insights into how a key protein called CLIC1 regulates the movement of immune cells in the brain and shapes their response to danger signals.…

A collaboration led by Max Delbrück Center and University of Bath has uncovered how ancient viral DNA controls a gene linked to placenta development and pre-eclampsia, a life-threatening pregnancy disorder. The research, published in “Genome…

Contrary to common assumptions, a new study from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and Charité – Universitätsmedizin Berlin, shows that intermittent fasting (time-restricted eating) with an unchanged calorie intake…

There are gender-specific risks after a kidney transplant. The GeGe4Nephro research project, led by Dr. Matthieu-P. Schapranow from the Hasso Plattner Institute for Digital Engineering, is dedicated to addressing these differences in order to improve…

IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH. Dosimetry portfolio strengthened with Medical Imaging QA and AI validation